Skip to main content

International Psoriasis Council

Advancing Knowledge. Improving Care.

Tamar

Nijsten

,

PhD

Principal Investigator
Erasmus MC
Rotterdam
,
Netherlands
Prof. Dr. Tamar Nijsten completed his medical school, dermatology residency, and defended his PhD at the University of Antwerp (Belgium). During his PhD in dermato-epidemiology, he was supervised by Prof. Dr. Robert Stern (Harvard Medical School). In the following years, Tamar established a dermato-epidemiology group at the Department of Dermatology Erasmus MC (Rotterdam, The Netherlands), resulting in a full professorship in dermatology in 2012 and a chair position in 2014. He has been President of the Dutch Society of Dermatology for four years. Since 2019, he has been the chair of the Erasmus MC Cancer Institute and the Clinical Director of the Children’s Hospital Sophia at the Erasmus MC.

The dermato-epidemiology research group of Tamar Nijsten consists of more than a dozen PhD students, several post-docs, and academic dermatologists. They apply epidemiology, public health, and clinical research principles on various skin conditions ranging from psoriasis, and varicose veins, to skin aging and cancer. The data sources are nationally routinely collected pharmacy and claim data, national cancer registry, population-based cohorts, or clinical cohorts. The goal has always been to deliver high-quality research introducing new concepts and methodologies to directly improve patient care and contribute to better organization of care.

Tamar Nijsten published over 375 peer-reviewed international papers in 2020 (H-index 60 – 80). He has given invited lectures at many international meetings, including the European Academy of Dermatology and Venereology (EADV), the European Society for Dermatological Research (ESDR), and the Society for Investigative Dermatology (SID), and at numerous national society meetings. He has received multiple grants from The Netherlands Organisation for Health Research and Development (ZonMw), including a personal Vidi grant in 2010. He was section editor of epidemiology for eight years for the Journal of Investigative Dermatology and holds this position currently for the British Journal of Dermatology.
Last Updated:
08/14/2023

What's New

Global and Collaborative Research in Psoriasis: IPC Fellows Research Class #1 Recordings

Recordings from the IPC Fellows Research Class #1: Global and Collaborative Research in Psoriasis are now available. Program Chairs Peter van de Kerkhof, MD, PhD, and María Julia Cura, MD, led a faculty of international experts through sessions on unresolved questions in the era of effective psoriasis therapies, building global research collaborations, and connecting psoriasis research across disciplines. Watch to hear from Wolf Henning Boehncke, MD, MA, Christopher Griffiths, OBE, MD, FMedSci, and Georg Stingl, MD, as they share perspectives shaping the next generation of psoriasis research.

WATCH NOW

Wednesday, July 15, 2026

New in the IPC Resource Library: Research Skills

The IPC Resource Library now includes a dedicated Research Skills category, bringing together videos, articles, and presentations focused on building stronger research capabilities in psoriasis. Browse the current collection to find resources on topics from collaborative research methods to career development for researchers at every stage.

WATCH NOW

Thursday, July 13, 2026

New Take Tens on Psoriatic Arthritis

IPC Councilor Anna Lopez Ferrer, MD, PhD, reviews PURE-4, a four-item tool that helps dermatologists screen psoriasis patients for psoriatic arthritis (PsA) risk. She traces its evolution across three studies (2018–2026) into a validated predictor of early PsA.

IPC Councilor André Lucas Ribeiro, MD, reframes PsA as a slow transition from psoriasis, not a sudden event, opening the door to disease interception. He outlines the steps needed to get there, from harmonizing definitions to reducing inflammatory burden.

WATCH NOW

Wednesday, July 8, 2026